It is licensed to A. The microspheres hold the medication in reserve, allowing the skin to absorb small amounts of tretinoin over time. RETIN-A(R) MICRO(TM) and RETIN-A(R) are marketed by Ortho Dermatological. (Nasdaq: APOS), a specialty pharmaceutical company focused on the development of ethical pharmaceuticals utilizing its proprietary drug delivery systems, today reported financial results for the three months ended March 31, 2001, and highlighted progress in the first quarter. Prescription acne market and is retin a micro prescription licensed to AP Pharma’s development and marketing partner, Ortho Dermatological, a member of the Johnson & Johnson family of companies. The company’s product development programs are funded by royalties from topical products currently marketed by pharmaceutical partners and proceeds from the divestiture of its cosmeceutical product lines. Initial targeted areas of application for the company’s drug delivery technology include pain management, inflammation, oncology, and ophthalmic and orthopedic applications. Findings from a study, published in the August issue of the dermatology journal CUTIS, demonstrate that retin a micro prescription retin-a MICRO significantly reduces the appearance of facial shine compared to RETIN-A 0. 025% Cream. Retin a micro prescription trade name, Retin-A Micro. The company’s primary focus is the development and commercialization of its bioerodible injectable and implantable systems under the trade name Biochronomer(TM). The Company’s primary focus is the development and commercialization of its bioerodible injectable and implantable systems under the trade name Biochronomer(TM). Severe retin a micro prescription cutaneous irritation occurred infrequently. Forward-looking Statements Except for historical information, this news release contains certain forward-looking statements that involve risks and uncertainties, including among others, uncertainty associated with timely development, approval, launch and acceptance of new products, Retin a micro prescription establishment of new corporate alliances and progress in research and development programs. The company does not undertake to revise these forward-looking statements to reflect events or circumstances occurring in the future. Health Editors retin a micro prescription skillman, N. –(BW HealthWire)–Aug. Sides of the face Retin a micro prescription treated with RETIN-A 0. 025% Cream did not show statistically significant reductions compared to baseline. Statistically significant reductions were reported by the investigator in the appearance of facial shine (oiliness) at three and six hours after application of RETIN-A MICRO as compared to baseline.